HTLV-1: Clinical Trials

6 trials for HTLV-1, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 2 Not applicable, 1 Phase 1, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 2
Phase 11Completed 1
Phase 31Completed 1
Phase 41Completed 1

Follow HTLV-1: new trials by email Literature Review of HTLV-1 trials Research Report on HTLV-1

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Darifenacin x Parasacral Transcutaneous Electric Nerve Stimulation for OAB in Patients Infected With Human T-Lymphotropic Virus 1
Darifenacin, Neuromodulation - Sacral nerve stimulation - HTLV-1, Overactive Bladder Syndrome
Phase 4CompletedHospital Universitário Professor Edgard Santos422022-03-162024-10-01
Sensorimotor Exercises in Virtual Reality Platform in Individuals With Human T-lymphotropic Virus
Video game - HTLV-1
Not applicableCompletedPedreira, Érika, M.D.422017-04-022019-06-06
Epidemic History and Iatrogenic Transmission of Blood-borne Viruses in Mid-20th Century Kinshasa
HIV, HTLV-1
CompletedUniversité de Sherbrooke8392012-06-012015-05-12
Urological Physical Therapy in HTLV-1 With Urinary Symptoms
Urological physical therapy - Tropical Spastic Paraparesis, HTLV-1
Not applicableCompletedHospital Universitário Professor Edgard Santos202012-03-012018-10-05
Use of Pentoxifylline in Human T-lymphotropic Virus Type-1 (HTLV-1) Diseases
Pentoxifylline, Placebo - HTLV-1, Tropical Spastic Paraparesis
Phase 3CompletedHospital Universitário Professor Edgard Santos482009-09-012015-03-18
Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
Hu MiK-Beta-1 - HTLV-1
Phase 1CompletedNational Institute of Neurological Disorders and Stroke (NINDS)92004-02-032019-06-27

Narrower conditions

Paraparesis, Tropical Spastic (3)  ·  Hepatitis C, Chronic (1)  ·  Immune System Diseases (1)  ·  Urinary Bladder, Neurogenic (1)  ·  Urinary Bladder, Overactive (1)

Broader conditions

Infections (4)  ·  RNA Virus Infections (4)  ·  Virus Diseases (4)  ·  Central Nervous System Diseases (3)  ·  Central Nervous System Infections (3)  ·  Deltaretrovirus Infections (3)  ·  HTLV-I Infections (3)  ·  Myelitis (3)  ·  Nervous System Diseases (3)  ·  Neuroinflammatory Diseases (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Retroviridae Infections (3)  ·  Spinal Cord Diseases (3)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)

Interventions

Behavior Therapy (1)  ·  Electric Stimulation Therapy (1)  ·  Hu-Mik-beta-1 monoclonal antibody (1)  ·  Musculoskeletal Manipulations (1)  ·  Pentoxifylline (1)  ·  darifenacin (1)

Sponsors

Hospital Universitário Professor Edgard Santos (3)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (1)  ·  Pedreira, Érika, M.D. (1)  ·  Université de Sherbrooke (1)

Countries

Brazil (4)  ·  United States (1)

Top investigators

Davi Costa, MD (1)  ·  Edgar M Carvalho, MD, PhD (1)  ·  Erika Fonseca, M.D. (1)  ·  Rosana Andrade, Master (1)  ·  Steven Jacobson, Ph.D. (1)

Results publications

PMID 26724409, PMID 29264126, PMID 32737862, PMID 34225282